Biological sample disposition [Bioanalytics]

posted by Ohlbe – France, 2009-08-31 01:47 (5793 d 00:02 ago) – Posting: # 4136
Views: 4,021

Dear Pranit,

❝ If sample discarded, then what will be the regulatory issue?


As far as I know: none. I am not aware of any requirement in any of the main BE guidelines (EU, USA, WHO...) requiring the plasma samples to be kept for any period of time once the trial is completed.

The main possible issue is if the re-analysis of the samples is needed once the list of questions is received from the authorities (if they want another analyte, or if problems are identified with the bioanalytical method used). But then you won't have sufficient long-term stability data anyway.

As Helmut says in his answer: make sure the retention period is specified in the contract.

Regards
Ohlbe

Complete thread:

UA Flag
Activity
 Admin contact
23,430 posts in 4,931 threads, 1,673 registered users;
40 visitors (0 registered, 40 guests [including 7 identified bots]).
Forum time: 01:50 CEST (Europe/Vienna)

To know that we know what we know,
and to know that we do not know what we do not know,
that is true knowledge.    Nicolaus Copernicus

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5